Metis Global Partners’s Abiomed Inc ABMD Stock Holding History

Metis Global Partners’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-900	Closed	-$221K	–	636
2022 Q3	$221K	Buy	+900	New	+$243K	0.04%	489
2022 Q2	–	Sell	-721	Closed	-$239K	–	575
2022 Q1	$239K	Buy	+721	New	+$222K	0.03%	491

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Metis Global Partners's ABMD Position: Q4 2022 in Review

Metis Global Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 900 shares — an estimated $221K sold.

Metis Global Partners first reported a position in ABMD in Q1 2022 and held it in 2 quarters. The position peaked at $239K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Metis Global Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Metis Global Partners sold 900 Abiomed Inc shares in Q4 2022, an estimated $221K.
Metis Global Partners first reported a position in Abiomed Inc in Q1 2022 and held it in 2 quarters.
Metis Global Partners's Abiomed Inc position peaked at $239K in Q1 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Metis Global Partners's 13F filing for Q4 2022, filed 7 Feb 2023.